Can a laser scan catch mouth cancer before it spreads?

NCT ID NCT07110623

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This trial tests a device that uses a laser to scan the inside of the mouth and help detect pre-cancer and cancer. Currently, doctors rely on their eyes to decide where to take a biopsy, which can miss early signs. The device collects molecular information from the tissue, and the study aims to train its software to recognize cancerous changes. Adults scheduled for an oral biopsy, plus healthy volunteers, will be scanned, and the results will be compared with biopsy reports.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
LIP device, a non-invasive laser scanner using polarized Raman spectroscopy to analyze mouth tissue
What this could lead to
If it works, this device could help doctors spot oral cancer earlier and guide biopsies more accurately, improving treatment success.
What could go wrong
This is a small pilot study focused on training the software, not proving it works in practice. The device may not reliably distinguish cancer from healthy tissue, and safety data is limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

40 people

The number who actually took part.

Started

Dec 2025

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants will be recruited from a single site at Guy's Hospital (London, UK). Patients with suspected pre-malignant or malignant condition (ie. having a "suspicious lesion") will be recruited from oral medicine and dental clinics at Guy's Hospital (London, UK) during their hospital appointment. Healthy volunteers will be recruited from staff and students at KCL and GSTT.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for patients 1. Adult aged 18 and older 2. One of the following criteria must be met: 1. Has a medical condition for which biopsy of oral tissue has been indicated. 2. Is undergoing inspection for early oral cancer 3. Willing and able to comply with all study procedures. Exclusion criteria for patients 1. Has a bleeding disorder, such as haemophilia, or has contraindication for having a biopsy. 2. Severe co-morbid illness, such as end-stage renal failure (ESRF), congestive cardiac failure (CCF), severe osteoarthritis (OA) and rheumatoid arthritis (RA) requiring long term non-steroidal anti-inflammatory drug (NSAID) therapy and any other immunosuppression / immuno-modulation therapy. 3. Has other severe acute or chronic medical or psychiatric condition where use of the device may cause unnecessary stress 4. Any condition that under judgment of the investigator would make the subject unsuitable as it may interfere with interpretation of study results 5. Currently using any compound recognised as acting as a light sensitizer / has a recognised condition associated with light sensitisation / tissue sensitivity to light such as photodynamic therapy or lupus. 6. Is pregnant or breastfeeding 7. Has a laboratory abnormality in medical record that may interfere with the interpretation of study results Inclusion criteria for healthy volunteers 1. Adult aged 18 and older. 2. Willing and able to comply with all study procedures. Exclusion criteria for healthy volunteers 1. Has a medical condition for which biopsy has been indicated or is undergoing inspection for early cancer. 2. Severe co-morbid illness, such as end-stage renal failure (ESRF), congestive cardiac failure (CCF), severe osteoarthritis (OA) and rheumatoid arthritis (RA) requiring long term non-steroidal anti-inflammatory drug (NSAID) therapy and any other immunosuppression / immuno-modulation therapy. 3. Has other severe acute or chronic medical or psychiatric condition where use of the device may cause unnecessary stress 4. Any condition that under judgment of the investigator would make the subject unsuitable as it may interfere with interpretation of study results 5. Currently using any compound recognised as acting as a light sensitizer / has a recognised condition associated with light sensitisation / tissue sensitivity to light such as photodynamic therapy or lupus. 6. Is pregnant or breastfeeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dysplasia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Oral Clinical Research Unit, Guy's Hospital

    London, Surrey, SE1 9RT, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.